Is Altria Group, Inc. (NYSE:MO) Currently Priced 41% Below Its Value?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 31 2025
0mins
Should l Buy MO?
Source: Yahoo Finance
Altria Group Valuation Analysis
- Fair Value Estimate: Altria Group's fair value is estimated at US$114, indicating a significant undervaluation of 41% compared to its current share price of US$67.21.
- Analyst Price Target: The average analyst price target for Altria is US$62.88, which is 45% lower than the fair value estimate.
Discounted Cash Flow (DCF) Model
- Methodology: The analysis employs a two-stage DCF model, which accounts for an initial high growth phase followed by a steady growth period. Future cash flows are estimated and discounted to present value.
- Projected Cash Flows: Expected levered free cash flows (FCF) from 2026 to 2035 are projected to grow from US$8.97 billion to US$11.5 billion, with growth rates gradually increasing from 1.70% to 2.85%.
- Present Value Calculation: The present value of the 10-year cash flows totals approximately US$69 billion, discounted at a rate of 7.7%.
Terminal Value and Total Equity Value
- Terminal Value Calculation: The terminal value is calculated at US$256 billion, using a conservative growth rate of 3.1% based on the 5-year average of the 10-year government bond yield.
- Total Equity Value: The total equity value, combining the present value of cash flows and terminal value, is estimated at US$191 billion, leading to a per-share valuation that suggests the stock is undervalued.
Financial Strengths and Weaknesses
- Strengths: Altria's earnings and cash flows adequately cover its debt and dividends, placing it in the top 25% of dividend payers in the market.
- Weaknesses: The company has experienced a decline in earnings over the past year, and total liabilities exceed total assets, raising financial distress concerns.
Future Outlook and Risks
- Growth Forecast: Annual earnings are expected to grow over the next three years, although at a slower rate compared to the broader American market.
- Investment Considerations: The analysis emphasizes that valuation is just one aspect of investment decisions, and potential investors should consider risks, future earnings growth, and alternative investment opportunities.
Conclusion
- Valuation Limitations: The DCF model is not foolproof and should be used to test assumptions rather than provide definitive valuations. Changes in growth rates or cost of equity can significantly alter outcomes.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MO
Wall Street analysts forecast MO stock price to fall
8 Analyst Rating
4 Buy
3 Hold
1 Sell
Moderate Buy
Current: 67.020
Low
57.00
Averages
65.00
High
72.00
Current: 67.020
Low
57.00
Averages
65.00
High
72.00
About MO
Altria Group, Inc. operates a portfolio of tobacco products for United States tobacco consumers aged 21+. Its segments include smokeable products and oral tobacco products. The smokeable products segment consists of combustible cigarettes and machine-made large cigars. The oral tobacco products segment includes moist smokeless tobacco (MST) products and oral nicotine pouches. Its wholly owned subsidiaries include manufacturers of both combustible and smoke-free products. In combustibles, it owns Philip Morris USA Inc. (PM USA), and John Middleton Co. (Middleton), which are cigarette manufacturers. Its smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (USSTC), a global MST manufacturer, Helix Innovations LLC (Helix), a manufacturer of oral nicotine pouches, and NJOY, LLC (NJOY), an e-vapor manufacturer with a commercialized product portfolio. The brand portfolios of its operating companies include Marlboro, Black & Mild, Copenhagen, Skoal, on! and NJOY.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Altria Expands Nicotine Pouch Business Nationwide
- Market Transformation: Altria is gradually pivoting its business model by expanding its nicotine pouch product line, branded as “on!”, from three states to nationwide availability following FDA approvals, although the net growth potential of this initiative appears limited, showcasing the company's adaptability to future market trends.
- Sales Data: Despite a nearly 10% decline in cigarette sales last year, Altria's oral tobacco product revenue only increased by less than 1%, indicating the challenges the company faces during its transition, particularly against the backdrop of a steadily declining smoking rate.
- Product Acceptance: While the retail expansion of nicotine pouches may boost revenue, most “on!” and “on! PLUS” products have been available online for some time, suggesting that consumer purchasing habits may not significantly change due to new retail channels, reflecting limitations in market acceptance.
- Dividend Appeal: Altria's forward-looking dividend yield stands at 6.7%, providing a reliable income source among risky assets, and although meaningful growth is limited, the company demonstrates strong management of the gradual decline of its cigarette business, ensuring long-term financial stability.
See More
Altria Stock Attracts Investors Back to Value
- Stock Price Surge: As of March 26, Altria (MO) has risen over 12% year-to-date, indicating investor preference for value stocks despite a sluggish overall market performance.
- Attractive Dividends: With a dividend yield of 6.5%, Altria has consistently increased its dividends for 57 consecutive years, earning it the title of 'Dividend King' and providing a competitive edge within the S&P 500.
- Market Challenges: While Altria leads the tobacco industry, the declining number of adult smokers in the U.S. poses a significant challenge; although the company has raised prices to offset volume declines, the long-term viability of this strategy is questionable.
- Investment Potential: Despite limited success in the smoke-free category, Altria's strong cash flow and ongoing shareholder return strategies, including a $1 billion stock buyback in 2025, continue to make it appealing to value investors.
See More
Altria Increases Dividend for 57 Consecutive Years
- Dividend Growth: Altria has increased its dividend for 57 consecutive years, currently boasting a 6.5% yield ($1.06 quarterly), ranking among the highest in the S&P 500, reflecting its strong commitment to shareholder returns.
- Market Challenges: Despite its impressive dividend record, the decline in U.S. adult smokers has led to falling volumes, forcing Altria to rely on price increases to offset this decline, a strategy that may not be sustainable in the long term.
- Investment Risks: Altria's attempts to establish a foothold in the smoke-free category have not yielded significant success, particularly with nearly $13 billion lost on its Juul investment and competition from Philip Morris International's Zyn, adding uncertainty to future growth prospects.
- Value Investment Opportunity: Despite these challenges, Altria is viewed as an ideal choice for value investors due to its strong cash flow and ongoing shareholder return strategies, making it particularly suitable for retirees seeking reliable income.
See More
Altria Faces Challenges in Tobacco Market
- Stock Performance Review: While Altria has historically achieved an annual return of 20%, its performance over the past decade has been lackluster due to declining smoking rates in the U.S., highlighting the vulnerability of its core business.
- Diversification Failures: Altria's investments in Cronos Group and Juul Labs have resulted in billions in losses, and its recent acquisition of NJOY faced a ban from the U.S. International Trade Commission due to patent infringement, exacerbating financial pressures.
- New Product Sales Growth: Despite the decline in its core business, Altria's On! oral nicotine pouches saw an 11% increase in sales to 177.8 million cans over the past year, but a drop in market share indicates competitive pressures, particularly from Philip Morris's Zyn.
- Future Earnings Outlook: Altria projects earnings per share growth of 2.5% to 5.5%, reaching $5.56 to $5.72 in 2026, and with a 6.3% dividend yield, it still presents some investment appeal despite the risks associated with its declining core business.
See More
Altria's Diversification Efforts Falter
- Core Business Decline: Altria has managed profit growth by raising cigarette prices, yet its 2025 revenue after excise taxes fell 1.5% to $20.1 billion, indicating a persistent decline in its core business and significant risks for future growth.
- New Product Market Competition: Altria's On! oral nicotine pouches saw an 11% shipment increase to 177.8 million cans over the past year, but a decline in market share in Q4 due to Zyn's promotions suggests limited market acceptance for new products.
- Shareholder Returns and Risks: Despite a roughly 50% stock price increase over the past two years, Altria's 2026 earnings per share target of $5.56 to $5.72, combined with a 6.3% dividend yield, highlights the challenges and uncertainties the company faces during its transition.
- Uncertain Industry Outlook: With smoking rates among young Americans continuing to decline, Altria's cigarette sales are almost certain to keep falling, and if the company cannot replace lost profits with new products, its long-term stock price will face downward pressure.
See More
Altria Group's Strategic Shift to New Products
- Market Expansion: Altria Group's 'on!' nicotine pouch products are expanding retail availability from three states to nationwide following FDA authorization, which is expected to significantly enhance product accessibility and drive sales growth.
- Industry Trends: According to Gallup data, smoking rates in the U.S. have declined from 54% in 1954 to 11% in 2024, highlighting the ongoing contraction of the traditional cigarette market and underscoring the importance of Altria's strategic pivot.
- Revenue Challenges: Despite some growth in oral tobacco product revenue, the overall cigarette sales declined by nearly 10%, indicating that Altria's performance in the alternative product market has not effectively compensated for the decline in its traditional business.
- Dividend Appeal: Altria's forward-looking dividend yield stands at 6.7%, providing an attractive option for income-seeking investors, although future growth potential appears limited, the company has demonstrated effective management of its gradual exit from the cigarette market.
See More
Altria Expands Nicotine Pouch Business Nationwide
- Market Transformation: Altria is gradually pivoting its business model by expanding its nicotine pouch product line, branded as “on!”, from three states to nationwide availability following FDA approvals, although the net growth potential of this initiative appears limited, showcasing the company's adaptability to future market trends.
- Sales Data: Despite a nearly 10% decline in cigarette sales last year, Altria's oral tobacco product revenue only increased by less than 1%, indicating the challenges the company faces during its transition, particularly against the backdrop of a steadily declining smoking rate.
- Product Acceptance: While the retail expansion of nicotine pouches may boost revenue, most “on!” and “on! PLUS” products have been available online for some time, suggesting that consumer purchasing habits may not significantly change due to new retail channels, reflecting limitations in market acceptance.
- Dividend Appeal: Altria's forward-looking dividend yield stands at 6.7%, providing a reliable income source among risky assets, and although meaningful growth is limited, the company demonstrates strong management of the gradual decline of its cigarette business, ensuring long-term financial stability.
See More
Altria Stock Attracts Investors Back to Value
- Stock Price Surge: As of March 26, Altria (MO) has risen over 12% year-to-date, indicating investor preference for value stocks despite a sluggish overall market performance.
- Attractive Dividends: With a dividend yield of 6.5%, Altria has consistently increased its dividends for 57 consecutive years, earning it the title of 'Dividend King' and providing a competitive edge within the S&P 500.
- Market Challenges: While Altria leads the tobacco industry, the declining number of adult smokers in the U.S. poses a significant challenge; although the company has raised prices to offset volume declines, the long-term viability of this strategy is questionable.
- Investment Potential: Despite limited success in the smoke-free category, Altria's strong cash flow and ongoing shareholder return strategies, including a $1 billion stock buyback in 2025, continue to make it appealing to value investors.
See More
Altria Increases Dividend for 57 Consecutive Years
- Dividend Growth: Altria has increased its dividend for 57 consecutive years, currently boasting a 6.5% yield ($1.06 quarterly), ranking among the highest in the S&P 500, reflecting its strong commitment to shareholder returns.
- Market Challenges: Despite its impressive dividend record, the decline in U.S. adult smokers has led to falling volumes, forcing Altria to rely on price increases to offset this decline, a strategy that may not be sustainable in the long term.
- Investment Risks: Altria's attempts to establish a foothold in the smoke-free category have not yielded significant success, particularly with nearly $13 billion lost on its Juul investment and competition from Philip Morris International's Zyn, adding uncertainty to future growth prospects.
- Value Investment Opportunity: Despite these challenges, Altria is viewed as an ideal choice for value investors due to its strong cash flow and ongoing shareholder return strategies, making it particularly suitable for retirees seeking reliable income.
See More
Altria Faces Challenges in Tobacco Market
- Stock Performance Review: While Altria has historically achieved an annual return of 20%, its performance over the past decade has been lackluster due to declining smoking rates in the U.S., highlighting the vulnerability of its core business.
- Diversification Failures: Altria's investments in Cronos Group and Juul Labs have resulted in billions in losses, and its recent acquisition of NJOY faced a ban from the U.S. International Trade Commission due to patent infringement, exacerbating financial pressures.
- New Product Sales Growth: Despite the decline in its core business, Altria's On! oral nicotine pouches saw an 11% increase in sales to 177.8 million cans over the past year, but a drop in market share indicates competitive pressures, particularly from Philip Morris's Zyn.
- Future Earnings Outlook: Altria projects earnings per share growth of 2.5% to 5.5%, reaching $5.56 to $5.72 in 2026, and with a 6.3% dividend yield, it still presents some investment appeal despite the risks associated with its declining core business.
See More
Altria's Diversification Efforts Falter
- Core Business Decline: Altria has managed profit growth by raising cigarette prices, yet its 2025 revenue after excise taxes fell 1.5% to $20.1 billion, indicating a persistent decline in its core business and significant risks for future growth.
- New Product Market Competition: Altria's On! oral nicotine pouches saw an 11% shipment increase to 177.8 million cans over the past year, but a decline in market share in Q4 due to Zyn's promotions suggests limited market acceptance for new products.
- Shareholder Returns and Risks: Despite a roughly 50% stock price increase over the past two years, Altria's 2026 earnings per share target of $5.56 to $5.72, combined with a 6.3% dividend yield, highlights the challenges and uncertainties the company faces during its transition.
- Uncertain Industry Outlook: With smoking rates among young Americans continuing to decline, Altria's cigarette sales are almost certain to keep falling, and if the company cannot replace lost profits with new products, its long-term stock price will face downward pressure.
See More
Altria Group's Strategic Shift to New Products
- Market Expansion: Altria Group's 'on!' nicotine pouch products are expanding retail availability from three states to nationwide following FDA authorization, which is expected to significantly enhance product accessibility and drive sales growth.
- Industry Trends: According to Gallup data, smoking rates in the U.S. have declined from 54% in 1954 to 11% in 2024, highlighting the ongoing contraction of the traditional cigarette market and underscoring the importance of Altria's strategic pivot.
- Revenue Challenges: Despite some growth in oral tobacco product revenue, the overall cigarette sales declined by nearly 10%, indicating that Altria's performance in the alternative product market has not effectively compensated for the decline in its traditional business.
- Dividend Appeal: Altria's forward-looking dividend yield stands at 6.7%, providing an attractive option for income-seeking investors, although future growth potential appears limited, the company has demonstrated effective management of its gradual exit from the cigarette market.
See More
